About UsMembershipMarketplaceResourcesGlobal Business Atlas
Top AI CompaniesTop Blockchain Influencers & AuthorsTop Global Digital AgenciesBusinessabc Country IndexesTop Accelerators and Chambers of CommerceTop Public Companies by MarketcapBusinessabc Education IndexesTop Malaysian Companies
DirectoryCompaniesLeadersInvestorsUniversitiesOrganisations
Loading wiki page…

Get Your Own Businessabc AI Visibility ID

Boost AI visibility, credibility, and discoverability

Learn More
Last Updated: 2026
Acerus Pharmaceuticals image

Acerus Pharmaceuticals

Summary
History
Mission
Vision
References
Summaryarrow
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; and Noctiva, a vasopressin analog indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void. It also engages in developing Lidbree, a short acting lidocaine formulation delivered through a proprietary device into the vaginal mucosal tissue; Stendra, a PDE5 inhibitor for the treatment of erectile dysfunction; Tefina, a clinical stage product for women with female sexual dysfunction; and Noctiva combination products, which are in the pre-clinical development stage for the treatment of benign prostatic hypertrophy, overactive bladder, and pediatric nocturnal enuresis. In addition, the company provides TriVair technology platform for pulmonary and nasal dosing. It sells its products through its salesforce in the United States and Canada; and through a network of distributors internationally. The company was formerly known as Trimel Pharmaceuticals Corporation and changed its name to Acerus Pharmaceuticals Corporation in September 2015. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada.
Historyarrow

Founded in 2007 and formerly known as Centric Health Corporation, Acerus began as an operator of pharmacies located in long-term care facilities throughout Canada, which evolved to creating a leading specialty pharmaceutical company by focusing on marketing, license and developing brands for the U.S. and Canada.

Missionarrow
Our mission is to enable access to safe, effective and high-quality healthcare products that help to improve the lives of those we serve.
Visionarrow
We strive to be trusted partners in healthcare, providing innovative and cost-effective treatment options that could benefit people around the world.
Referencesarrow

https://in.investing.com/equities/trimel-pharmaceuticals-corporation

https://finance.yahoo.com/quote/ASP.TO/profile?p=ASP.TO

https://www.crunchbase.com/organization/acerus-pharmaceuticals-corporation

https://www.aceruspharma.com

Share

Leadership team
M
Mr. Edward Gudaitis (Pres, CEO & Director)
M
Mr. Gavin Damstra (Sr. VP of International Commercial)
D
Dr. Christopher Sorli F.A.C.E., M.D., Ph.D. (Chief Medical Officer)
Products / Services
Clinical Trials, Medical, Pharmaceutical
Number of Employees
0 - 50
Address
Mississauga, Ontario, Canada
Established
2008-01-01
Revenue
2M - 5M
Traded as
TSX:ASP
Website
https://www.aceruspharma.com
Social Media
linkedin
Last Updated: 2026
Logo

Businessabc provides digital business directory, digital blockchain AI certification, resources, and marketplace for businesses, organisations, and professionals.

Contacts

Email
Contact

Follow Us

Created Produced

Partner logo
Partner logo

Tech AI Media Platforms

Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo

Copyright 2026 © Businessabc powered by

Powered by ztudium group

DisclaimerPrivacy PolicyTerms of Service
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo
Partner logo